Massachusetts Biopharma Sees Capital Resurgence Even as Jobs Post First Annual Decline
Massachusetts’ biopharma industry saw employment shrink by 3.1% in 2025 to 113,503 jobs, the first annual decline in the two decades that industry association MassBio has tracked the sector. Conversely, MassBio’s 2026 Industry Snapshot found that venture capital, initial public…
Massachusetts’ biopharma industry saw employment shrink by 3.1% in 2025 to 113,503 jobs, the first annual decline in the two decades that industry association MassBio has tracked the sector. Conversely, MassBio’s 2026 Industry Snapshot found that venture capital, initial public…
BELLINGS Intelligence Score: 15
Why it matters
The report highlights a sector-specific employment decline alongside capital inflows in Massachusetts biopharma, which is notable for regional credit and investment professionals but does not materially affect broader credit markets or underwriting standards.
Sources
Connect CRE
Massachusetts Biopharma Sees Capital Resurgence Even as Jobs Post First Annual Decline
Massachusetts’ biopharma industry saw employment shrink by 3.1% in 2025 to 113,503 jobs, the first annual decline in the two decades that industry association MassBio has tracked the sector. Conversely, MassBio’s 2026 Industry Snapshot found that venture capital, initial public…